Results 21 to 30 of about 21,426,149 (319)
IDB Group Selected Development Contributions 2016-2019
, 2020 This infographic shows selected IDB Group\u27s contributions to the Sustainable Development Goals (SDGs) reported through the Group\u27s Corporate Results Framework between 2016 and ...
Inter-American Development Bank
core +1 more source
Cytomics and drug development [PDF]
Cytometry Part A, 2007 Drug discovery is fundamentally focused on increasing the number and novelty of medicines, while containing the associated costs. High costs impact on healthcare delivery and the range of diseases for which medicines become available. Pace has been increased via combinatorial chemistry, genomics knowledge, proteomics technologies, new target validation
Paul J, Smith, I A, Khan, R J, Errington
openaire +2 more sources
, 2007 openAccessArticle: False ; cover date: 2015-01-01 ; pii: B978-0-12-801238-3.04980-1 ; Harvest Date: 2016-01-06 13:08:13 ; issueName: ; Page Range: - ; href scidir: http://www.sciencedirect.com/science/article/pii/B9780128012383049801 ; pubType:
L., Wecker, Wecker, L., Krzanowski, J.
openaire +3 more sources
Development Effectiveness Overview (DEO) 2020
, 2020 The Development Effectiveness Overview (DEO) is an annual report produced by the IDB Group to share the results and impact of its work in Latin America and the Caribbean.
Inter-American Development Bank
core +1 more source
The IDB Group and the Sustainable Development Goals [PDF]
, 2022 The IDB Group is committed to supporting countries in Latin America and the Caribbean accelerating progress toward the Sustainable Development Goals.
Inter-American Development Bank
core +1 more source
Development Effectiveness Overview (DEO) 2020: Executive Summary
, 2020 The Development Effectiveness Overview (DEO) is an annual report produced by the IDB Group to share the results and impact of its work in Latin America and the Caribbean.
Inter-American Development Bank
core +1 more source
BMC Cancer, 2021 An amendment to this paper has been published and can be accessed via the original article.
Dearbhaile Catherine Collins +11 more
doaj +1 more source
Drug metabolism in drug discovery and development
Acta Pharmaceutica Sinica B, 2018 Drug metabolism as a discipline plays an important role in drug discovery and development and the effects of drug metabolism on pharmacokinetics (PK), pharmacodynamics (PD), and safety should be carefully considered. This communication provides an overview of common strategies in the area of drug metabolism for improving PK/PD and safety profiles of ...
Zhoupeng Zhang, Wei Tang
openaire +3 more sources
Melatonergic drugs in development
Clinical Pharmacology: Advances and Applications, 2014 Melatonin (N-acetyl-5-methoxytryptamine) is widely known as "the darkness hormone". It is a major chronobiological regulator involved in circadian phasing and sleep-wake cycle in humans. Numerous other functions, including cyto/neuroprotection, immune modulation, and energy metabolism have been ascribed to melatonin.
CAROCCI, ALESSIA +2 more
openaire +6 more sources
Pharmacogenomics and Drug Development [PDF]
Pharmacogenomics, 2005 It is generally anticipated that pharmacogenomic information will have a large impact on drug development and will facilitate individualized drug treatment. However, there has been relatively little quantitative modeling to assess how pharmacogenomic information could be best utilized in clinical practice.
Yingying, Guo +4 more
openaire +2 more sources